Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,065 | 76 | 99.5% |
| Education | $5.38 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $242.72 | 26 | $0 (2018) |
| PFIZER INC. | $163.50 | 11 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $109.79 | 7 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.01 | 5 | $0 (2019) |
| Lilly USA, LLC | $59.96 | 4 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $54.74 | 4 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $39.94 | 2 | $0 (2022) |
| Abbott Laboratories | $38.78 | 2 | $0 (2019) |
| Allergan Inc. | $31.53 | 2 | $0 (2017) |
| Medtronic MiniMed, Inc. | $31.06 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $26.52 | 1 | BioCryst US Sales Co., LLC ($26.52) |
| 2022 | $83.83 | 5 | Bayer HealthCare Pharmaceuticals Inc. ($39.94) |
| 2021 | $21.40 | 1 | BioFire Diagnostics, LLC ($21.40) |
| 2020 | $157.30 | 11 | PFIZER INC. ($142.69) |
| 2019 | $83.51 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27.85) |
| 2018 | $361.27 | 33 | GlaxoSmithKline, LLC. ($188.53) |
| 2017 | $336.09 | 22 | Sunovion Pharmaceuticals Inc. ($109.79) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/18/2023 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Immunology | ||||||
| 10/31/2022 | Seqirus USA Inc | Fluad Quadrivalent (Biological), FLUCELVAX QUADRIVALENT | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Vaccines | ||||||
| 07/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Cardio-renal | ||||||
| 06/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Cardio-renal | ||||||
| 05/26/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 04/13/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Diabetes | ||||||
| 08/24/2021 | BioFire Diagnostics, LLC | FilmArray (Device) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Clinical Diagnostics | ||||||
| 12/10/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/06/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/08/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/11/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/28/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/11/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Neuroscience | ||||||
| 03/05/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/18/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/22/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/13/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/04/2019 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Diabetes Care | ||||||
| 05/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: RESPIRATORY | ||||||
| 04/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: DIABETES | ||||||
| 12/19/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: RESPIRATORY | ||||||
| 11/28/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 635 | 1,082 | $167,578 | $82,436 |
| 2022 | 13 | 741 | 1,159 | $155,651 | $71,221 |
| 2021 | 16 | 934 | 1,338 | $143,707 | $68,463 |
| 2020 | 11 | 732 | 1,101 | $151,277 | $55,919 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 112 | 208 | $35,568 | $20,567 | 57.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 117 | 124 | $35,960 | $20,502 | 57.0% |
| G0317 | Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualifi | Facility | 2023 | 114 | 357 | $18,207 | $9,852 | 54.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 75 | $18,750 | $7,111 | 37.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 30 | 36 | $8,820 | $5,091 | 57.7% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 67 | 69 | $9,177 | $4,713 | 51.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 65 | $9,750 | $4,097 | 42.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 33 | 33 | $6,996 | $4,029 | 57.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $7,000 | $2,748 | 39.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 27 | 27 | $5,400 | $1,748 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 35 | $7,000 | $1,472 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 33 | $4,950 | $506.14 | 10.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 175 | 459 | $68,850 | $27,509 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 294 | $58,750 | $22,460 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 83 | 83 | $12,450 | $10,606 | 85.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 73 | 74 | $4,300 | $2,761 | 64.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 59 | $2,950 | $1,812 | 61.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $1,950 | $1,703 | 87.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 21 | $1,175 | $1,142 | 97.2% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 29 | 29 | $1,450 | $1,121 | 77.3% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 27 | 28 | $1,820 | $1,096 | 60.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 29 | 29 | $1,305 | $610.64 | 46.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $650.00 | $399.99 | 61.5% |
| 91313 | Coronavirus vaccine 14 | Office | 2022 | 29 | 29 | $0.29 | $0.29 | 100.0% |
| 91306 | Sarscov2 vac 50mcg/0.25ml im | Office | 2022 | 27 | 28 | $0.28 | $0.28 | 100.0% |
About Dr. Madhava Narala, M.D
Dr. Madhava Narala, M.D is a Critical Care Medicine healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447246699.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Madhava Narala, M.D has received a total of $1,070 in payments from pharmaceutical and medical device companies, with $26.52 received in 2023. These payments were reported across 78 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,065).
As a Medicare-enrolled provider, Narala has provided services to 3,042 Medicare beneficiaries, totaling 4,680 services with total Medicare billing of $278,039. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Hospitalist, Internal Medicine
- Location Fresno, CA
- Active Since 09/23/2005
- Last Updated 03/07/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1447246699
Products in Payments
- ANORO (Drug) $158.50
- CHANTIX (Drug) $133.40
- UTIBRON (Drug) $109.79
- TRELEGY ELLIPTA (Drug) $68.34
- TRADJENTA (Drug) $51.64
- INVOKANA (Drug) $42.77
- Kerendia (Drug) $39.94
- iPro2 (Device) $31.06
- ELIQUIS (Drug) $30.10
- ENTRESTO (Drug) $28.63
- SPIRIVA RESPIMAT (Drug) $27.85
- TRULICITY (Drug) $27.02
- ORLADEYO (Drug) $26.52
- XIFAXAN (Drug) $26.50
- FilmArray (Device) $21.40
- Prolia (Biological) $20.05
- Santyl (Drug) $19.93
- NAMZARIC (Drug) $19.92
- FreeStyle Libre (Device) $19.89
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $18.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Fresno
Dr. Vijai Daniel, M.d, Mph, M.D, MPH
Critical Care Medicine — Payments: $439,189
Dr. Lovrdu Pyreddy, M.d, M.D
Critical Care Medicine — Payments: $13,735
Mr. Kuldeep Gill, M.d, M.D
Critical Care Medicine — Payments: $13,598
Dr. Pankaj Mehta, Md, MD
Critical Care Medicine — Payments: $13,109
Rachel Donaldson, Md, Ms, MD, MS
Critical Care Medicine — Payments: $623.84
Dr. Paul Goebel, M.d, M.D
Critical Care Medicine — Payments: $505.92